Skip to main content

James R. Goldenring, M.D., Ph.D.

  • Paul W. Sanger Professor of Experimental Surgery
  • Professor of Surgery
  • Professor of Cell and Developmental Biology
  • Vice Chair, Surgical Research

Phone

615-936-3726

Email

jim.goldenring@vanderbilt.edu
Vanderbilt University Medical Center
10435-G Medical Research Building IV
Nashville, TN 37232-8240

James R. Goldenring, M.D., Ph.D.

  • Paul W. Sanger Professor of Experimental Surgery
  • Professor of Surgery
  • Professor of Cell and Developmental Biology
  • Vice Chair, Surgical Research

615-936-3726

jim.goldenring@vanderbilt.edu

Vanderbilt University Medical Center
10435-G Medical Research Building IV
Nashville, TN 37232-8240

Departments/Affiliations

Profile

Education

Research Emphasis

Gastric cancer
Vesicle trafficking
Protein kinases
Rab proteins
A-kinase anchoring proteins
Congenital diarrhea
Neonatal Diarrhea
Metaplasia
Pre-cancer
Centrosomes
Golgi apparatus
Membrane recycling
Apical recycling systems
Endocytosis
Myosin V
Gastric parietal cell
Gastric metaplasia
Epithelial biology
RNA trafficking
stress granules
Cancer
Protein structure

Research Description

James R. Goldenring, MD, PhD


Dr. Goldenring’s research spans multiple topics across the broad area of epithelial biology. He has been a leader in investigation of the roles of specific roles of Rab small GTPases and their effectors in regulating vesicle trafficking, membrane recycling and polarity in polarized cells. His recent studies are focused on how these small GTPases may regulate cell polarity and the initiation of gastrointestinal cancers. He is presently studying the role of specific defects in apical vesicle trafficking in the etiology of neonatal diarrhea syndromes in human. His recently published work defined the role of Rab11a and Rab8a interactions with myosin Vb in the development of severe neonatal diarrhea in children with Microvillus Inclusion Disease and he has recently published work on the phenotypes of mouse models of MYO5B KO. The laboratory is now analyzing the newly developed mouse models for targeted loss of MYO5B, Rab11a and Rab11-FIP2 in the intestines and other organs. Other work in the Goldenring laboratory is defining the role of Par1b/MARK2 phosphorylation of Rab11-FIP1 and Rab11-FIP2 on the establishment and maintenance of polarity. These studies are utilizing phosphorylation site-specific antibodies as well as Rab11-FIP mutants to define defects in trafficking and polarity. Dr. GOldenring is alsoinbestigating the causes of congenital diarrheal diseases as one of the four lead investigators in the Pediatric Congenital Diarrhea Consortium (PediCODE).
In addition to his studies of epithelial polarity, Dr. Goldenring also studies the mechanisms responsible for the development of pre-neoplastic lineages from metaplasias in the stomach and their roles in gastric carcinogenesis. These investigations focus on defining how mature chief cells transdifferentiate into pre-neoplastic metaplasia in the stomach. Recent work has demonstrated that M2 macrophages are necessary for conversion of metaplasia into a proliferative and intestinalizing metaplasia. Other studies have demonstrated that activation of Ras is critical for multiple stages of induction and progression of metaplasia and may represent a focus for clinical intervention in gastric pre-cancer. On going studies focus on understanding the mechanisms responsible for the process of transdifferentiation and how immune regulators influence this process.

Publications

Have any questions? Contact Us 1-877-936-8422 for more information